Marked mitigation of transplant vascular sclerosis in FasL(gld) (CD95L) mutant recipients. I. The role of alloantibodies in the development of chronic rejection

Transplantation

Volumn 67, Issue 10, 1999, Pages 1295-1300

  Subbotin, Vladimir ^a   Sun, Hong ^a   Aitouche, Abdelouahab ^a   Salam, Abdus ^a   Valdivia, Luis A ^a   Fung, John J ^a   Starzl, Thomas E ^a   Rao, Abdul S ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; FAS ANTIGEN;

ANIMAL MODEL; ANIMAL TISSUE; AORTA GRAFT; ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; HISTOPATHOLOGY; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; ANTIGENS, CD95; AORTA; APOPTOSIS; ARTERIOSCLEROSIS; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; ISOANTIBODIES; LIGANDS; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED MRL LPR; POINT MUTATION;

EID: 0033609269     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199905270-00001     Document Type: Article

References (36)

1. Berke G. The CTL's kiss of death. Cell 1995; 81(1): 9.
2. Lau HT, Yu M, Soeckert CJ Jr. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 1996; 273: 109.
3. Yamagami S, Kawashima H, Tsuru T, et al. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 1997; 64(8): 1107.
4. Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995; 16(1): 39.
5. Suda T, Okazaki T, Naito Y, et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995; 154(8): 3806.
6. Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S, Goldstein P. TcR/CD3 coupling to Fas-based cytotoxicity. J Exp Med 1995; 181(2):781.
7. Bellgrau D, Gold D, Selawry H, Moore J, Franzushoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630.
8. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189.
9. Rouvier E, Luciani MF, Goldstein P. Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J Exp Med 1993; 177(1): 195.
10. Suda T, Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994; 179(3): 873.
11. Kagi D, Vignaux F, Ledermann, et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265: 528.
12. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994; 370: 650.
13. Andrews BS, Eisenberg RA, Theofilopoulos AN, et al. Spontaneous murine lupus-like syndromes: clinical and immunopathological manifestations in several strains. J Exp Med 1978; 148(5): 1198.
14. Kobayashi S, Hirano T, Kakinuma M, Uede T. Transcriptional repression and differential splicing of Fas mRNA by early transposon (ETn) insertion in autoimmune lpr mice. Biochem Biophys Res Commun 1993; 191(2): 617.
15. Watson ML, D'Eustachio P, Mock BA, et al. A linkage map of mouse chromosome 1 using an interspecific cross segregating for the gld autoimmunity mutation. Mamm Genome 1992; 2(3): 158.
16. Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76(6): 969.
17. Sun H, Valdivia LA, Subbotin V, et al. Improved surgical technique for the establishment of a murine model of aortic transplantation. Microsurgery 1998; 18: 368.
18. Subbotin V, Sun H, Aitouche A, et al. Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. Transplantation 1997; 64(5): 690.
19. Sun H, Subbotin V, Chen C, et al. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation 1997; 64(12): 1838.
20. Bradbury R, Gordon KC. Theory and practice of histological techniques. In: Bancroft JD, Stevens A, eds. New York: Churchill Livingston Press, 1990: 119.
21. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against a smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986; 103: 2787.
22. Montel AH, Bochan MR, Hobbs JA, Lynch DH, Brahmi Z. Fas involvement in cytotoxicity mediated by human NK cells. Cell Immunol 1995; 166(2): 236.
23. + T cells. Nature 1995; 376: 181.
24. Brunner T, Mogil RJ, LaFace D, et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995; 373: 441.
25. Cohen PL, Eisenberg RA. The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol Today 1992; 13(11): 427.
26. Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81(6): 935.
27. Griffith TS, Ferguson TA. The role of FasL-induced apoptosis in immune privilege. Immunol Today 1997; 18(5): 240.
28. Larsen CP, Alexander DZ, Hendrix R, Ritchie SC, Pearson TC. Fas-mediated cytotoxicity: an immunoeffector or immunoregulatory pathway in T cell-mediated immune responses? Transplantation 1995; 60(3): 221.
29. Hayry P, Isoniemi H, Yilmaz S, et al. Chronic allograft rejection. Immunol Rev 1993; 134: 33.
30. Basadonna GP, Matas AJ, Gillingham KJ, et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993; 55(5): 993.
31. Tilney NL, Whitley WD, Diamond JK, Jupiec-Weglinski JW, Adams DH. Chronic rejection: an undefined conundrum. Transplantation 1991; 52(3): 39.
32. Russell PS, Chase CM, Colvin RB. Alloantibody-and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis. Transplantation 1997; 64: 1531.
33. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol 1994; 152: 5135.
34. Reemtsma K. Vascular immunoobliterative disease: a common cause of graft failure. Transplant Proc 1989; 21: 3706.
35. Mohanakumar T, Rhodes C, Mendez-Picon G, Goldman M, Moncure C, Lee H: Renal allograft rejection associated with presensitization to HLA-DR antigens. Transplantation 1981; 31: 93.
36. O'Connell TX, Mobray JF. Arterial intimal thickening produced by alloantibody and xenoantibody. Transplantation 1973; 51: 262.